APOA1 and angina pectoris: Indeed using an optimized mimetic peptide to diagnose the occurrence of an acute ischemic coronary event (non-ST segment elevation myocardial infarction and unstable angina) on a cohort of acute chest pain patients, we were able to approach the diagnostic accuracy obtainable using intact endogenous ApoA-I.